AzTrials
AzTrials

Covid19NCT04979858

Reducing Spread of COVID-19 in a University Community Setting: Role of a Low-Cost Reusable Form-Fitting Fabric Mask

A study testing Focal Mask in people with Covid19 and SARS-CoV2 Infection, run by Georgia Institute of Technology at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The primary aim of the proposed research is to test the role of a newly developed reusable form-fitting fabric mask in reducing the spread of COVID-19 in a community setting comprising undergraduate students living in dormitories at the Georgia Institute of Technology (Georgia Tech). Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Covid19, SARS-CoV2 Infection
What is being tested?
Focal Mask
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
201 participants
Where
1 siteUnited States
Study dates
6 Sep 2021to 15 Mar 2022
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Georgia Institute of Technology (Georgia Tech) student
  • 18 years old or older
  • Living on campus in Georgia Tech dorms

Who cannot join

  • Not a Georgia Tech student
  • Under the age of 18
  • Not living on campus in Georgia Tech dorms

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Georgia Institute of Technology - Main Campus

    Atlanta, Georgia, 30332

Other trials in United States

About this study

Official title: Reducing Spread of COVID-19 in a University Community Setting: Role of a Low-Cost Reusable Form-Fitting Fabric Mask for Community Use

The primary aim of the proposed research is to test the role of a newly developed reusable form-fitting fabric mask in reducing the spread of COVID-19 in a community setting comprising undergraduate students living in dormitories at the Georgia Institute of Technology (Georgia Tech). A corollary aim is to assess the role of wearing any type of face covering in reducing spread in the same community setting. A final aim is to assess the social, behavioral, aesthetic, and usability aspects of wearing face coverings in public settings.

Read the detailed description

The primary aim of the proposed research is to test the role of a newly developed reusable form-fitting fabric mask in reducing the spread of COVID-19 in a community setting comprising undergraduate students living in dormitories at Georgia Tech. The study has been designed such that it also leads to the corollary aim of assessing the role of wearing any type of face covering in reducing spread in the same community setting. Yet another aim is to assess the social, behavioral, aesthetic, and usability aspects of wearing face coverings in public settings. The study design is to assign student users of masks randomly to the Treatment group of focal mask users (n=100) and a Control group of other mask users (n=100).

The Study Population and Data Collection: The subject population will comprise 200 undergraduate students staying in the dormitories at Georgia Tech, preferably freshmen and sophomores with meal plans. There will be no restriction of race, gender, or sexual orientation for this study. The final cohort chosen will attempt to reflect the demographics of the undergraduate student body at Georgia Tech. The participating subjects will have the option to withdraw from the study at any time. The recruitment of subjects will be carried out in collaboration with Georgia Tech Housing through e-mail and web announcements. The research team will be accessible to the subjects at all times during the study.

As part of the informed consent process during recruitment, the Treatment Group will be told about the use, care and laundering of the focal mask during the study. The planned sample size of 200 accounts for dropouts, which are likely to occur so that a statistically significant sample is present to assess the effect of the mask. A randomized study cannot be undertaken for ethical and practical reasons (e.g., the fact that the behaviors of students cannot be controlled leading to heterogeneity); therefore, a DID (Difference-in-Difference) approach that has been used extensively in public health research will be utilized in this study . The DID method assumes that unobserved heterogeneity in participation is present but that such factors are time invariant. With data on observations before and after the treatment intervention, this fixed component can be differenced out. For this reason, the study is spread over six weeks consisting of three phases: Pre-treatment, Treatment, and Post-treatment, with each phase lasting two weeks. The two-week period for each phase is based on the following rationale: The incubation period of COVID-19 virus has been found to be five days. About 97% of the people who get infected and develop symptoms will do so within 11 to 12 days, and about 99% will within 14 days, which is the basis for the 14-day quarantine recommended by Centers of Disease Control. The health and well-being of the subjects will be tracked during the study. Any student falling sick will be given medical help using on-campus health services. Georgia Tech has a system in place with the ability to conduct 1,500 tests per day, going to possibly 3,000 per day. If the COVID-19 test is positive, the subject will be excluded from the remainder of the study. The subject will, however, be compensated at the end of the study.

Data Collection: During the study, demographic, behavioral, and mask use data will be recorded and appropriately de-identified. No specimens will be obtained from the subjects. All the collected data will be access limited, and destroyed when no longer needed to perform the study or analysis or after completion and publication of the study, whichever comes first. COVID-19 diagnoses will be self-reported by the subjects.

At the beginning of the study, each subject will provide the following data:

  • Subject Profile: Demographic information, class schedule, dining plans
  • Baseline Practice Data: Mask usage practice (type, duration), typical social interactions
  • During the study, each subject will provide the following data every day:
  • Health Metrics: Temperature, Typical COVID-19 symptoms (if any)
  • Mask Usage Data: Type and duration of mask usage including washing
  • Activity Data: Classes attended, group meetings, social and dining interactions

At the end of the study, each subject will provide the following data:

  • Usability: Comfort, Ease of Donning/Doffing, Impact on Communication
  • Shape Conformability: Conforms to face, Shape retention after washing
  • Ease of Care: Ease of washing
  • Aesthetic and Social Perceptions: Style, Perceptions of others, Impact on personal behavior and degree of social interactions

The Difference-in-Difference (DID) methodology will be used to analyze the data from the Control and Treatment groups. The difference in infection rates between the groups will help determine the role of the focal mask.

Being tested
Focal Mask
Keywords
Reusable masks, University Setting
Medical subject headings
COVID-19

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Focal MaskDevice

    The treatment group will receive and use the focal mask.

Study groups in NCT04979858
Study groupRoleWhat they receive
Control GroupNo interventionThe subjects will choose their own mask and masking practices.
Treatment GroupExperimentalThe treatment group will receive and use the focal mask.
Receives: Device: Focal Mask

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of Participants Not Infected by COVID-19

    Number of participants not infected by COVID-19 in a university setting.

    Measured: 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jul 2021
  2. Study start6 Sep 2021
  3. Primary completion30 Oct 2021
  4. Study completion15 Mar 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
One group will receive the focal mask and the other group will choose its own mask.
Masking
Single blind
Who is masked
Investigator
Enrolment
201 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04979858
Sponsor's protocol ID
H21218
Other IDs
75D30121C10545
Status last verified
Mar 2023
First submitted
22 Jul 2021
Last updated
3 Apr 2023
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Focal Mask in people with Covid19 and SARS-CoV2 Infection, run by Georgia Institute of Technology at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Apr 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 3 Apr 2023). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of Participants Not Infected by COVID-19 (time frame: 4 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Apr 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in